A new rare blood group antigen - "Mit". Probably genetic relationship with the MNSs blood group system

Area of Science:

• Immunology
• Genetics
• Hematology

Background:

• Hemolytic disease of the newborn (HDN) is a significant concern in perinatal care.
• Existing blood group systems (ABO, Rh, Duffy, Kidd, Yt) do not fully account for all cases of immunization-related HDN.
• The identification of new blood group antigens is crucial for improving transfusion compatibility and understanding immune-mediated obstetric complications.

Purpose of the Study:

• To describe a newly discovered low-incidence blood group antigen, designated
• Mit
• .
• To investigate the potential association of the
• Mit
• antigen with known blood group systems, particularly the MNSs system.
• To highlight the clinical relevance of the
• Mit
• antigen in cases of hemolytic disease of the newborn.

Main Methods:

• Serological characterization of a novel blood group antigen.
• Exclusion of the antigen from established blood group systems (ABO, Duffy, Kidd, Rh, Yt).
• Lod score analysis to determine genetic linkage with the MNSs blood group system loci (MN and Ss).

Main Results:

• A new low-incidence blood group antigen,
• Mit
• , was identified.
• The
• Mit
• antigen is distinct from the ABO, Duffy, Kidd, Rh, and Yt blood group systems.
• Lod score analysis yielded positive lods of +2.41 (at O = 0.00), strongly suggesting that the
• Mit
• antigen is either part of the MNSs system or closely linked to the MN and Ss loci.

Conclusions:

• The
• Mit
• blood group antigen represents a novel entity in human blood group serology.
• Immunization to the
• Mit
• antigen poses a risk for hemolytic disease of the newborn.
• The genetic linkage of
• Mit
• to the MNSs system warrants further investigation and has implications for population genetics and transfusion practices.